Tommy Idrovo-Hidalgo

Tommy Idrovo-Hidalgo

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2023 in Fermentation
Verified
Journal Article
Open access
PDF file
DNDiego G. Noseda
Diego G. Noseda
CDCecilia D'Alessio
Cecilia D'Alessio
Javier SantosJavier Santos
Javier Santos
TITommy Idrovo-Hidalgo
Tommy Idrovo-Hidalgo
MPMaría Florencia Pignataro
María Florencia Pignataro
LRLucas Adolfo Mauro Ruberto
Lucas Adolfo Mauro Ruberto
SARS-CoV-2 was identified as the pathogenic agent causing the COVID-19 pandemic. Among the proteins codified by this virus, the Spike protein is one of the most-external and -exposed. A fragment of the Spike protein, named the receptor binding domain (RBD), interacts with the ACE2 receptors of human cells, allowing the entrance of the viruses. RBD has been proposed as an interesting protein for the development of diagnosis tools, treatment, and prevention of the disease. In this work, a method for recombinant RBD production using Pichia pastoris as a cell factory in a stirred-tank bioreactor (SRTB) up to 7 L was developed. Using a basal saline medium with glycerol, methanol, and compressed air in a four-stage procedure, around 500 mg/L of the raw RBD produced by yeasts (yRBD) and 206 mg/L of purified (>95%) RBD were obtained. Thereby, the proposed method represents a feasible, simple, scalable, and inexpensive procedure for the obtention of RBD for diagnosis kits and vaccines’ formulation.

24 April 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
DNDiego Noseda
Diego Noseda
CDCecilia D'Alessio
Cecilia D'Alessio
Javier SantosJavier Santos
Javier Santos
TITommy Idrovo-Hidalgo
Tommy Idrovo-Hidalgo
MPMaría Florencia Pignataro
María Florencia Pignataro
LRLucas Adolfo Mauro Ruberto
Lucas Adolfo Mauro Ruberto
SARS-CoV-2 was identified as the pathogenic agent causing the COVID-19 pandemic. Among the proteins codified by this virus, the Spike is one of the most external and exposed. A fragment of the Spike protein, named the Receptor Binding Protein (RBD) interacts with the ACE2 receptors of human cells, allowing the entrance of the viruses. RBD has been proposed as an interesting protein for the development of diagnosis tools, treatment and prevention of the disease. In this work, a method for recombinant RBD production using Pichia pastoris as a cell factory in a Stirred Tank Bioreactor (SRTB) up to 7 L was developed. Using a basal saline medium with glycerol, methanol and compressed air in a four stages procedure, around 500 mg/L of raw yRBD (RBD produced by yeasts) and 206 mg/L of purified (>95%) RBD were obtained. Thereby, the proposed method represents a feasible, simple, scalable and cheap procedure for the obtention of RBD for diagnosis kits and vaccines formulation